摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-Aminoethyl)-2-(2.6-diisopropylphenylimino)-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-pyrimido[6.1-a]isoquinolin-4-one | 298680-45-2

中文名称
——
中文别名
——
英文名称
3-(2-Aminoethyl)-2-(2.6-diisopropylphenylimino)-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-pyrimido[6.1-a]isoquinolin-4-one
英文别名
3-(2-Aminoethyl)-2-(2,6-diisopropylphenylimino)-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one;3-(2-aminoethyl)-2-[2,6-di(propan-2-yl)phenyl]imino-9,10-dimethoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one
3-(2-Aminoethyl)-2-(2.6-diisopropylphenylimino)-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-pyrimido[6.1-a]isoquinolin-4-one化学式
CAS
298680-45-2
化学式
C28H36N4O3
mdl
——
分子量
476.619
InChiKey
NOMZWYUAHCJJOG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    35
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    80.4
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Sodium cyanate 、 3-(2-Aminoethyl)-2-(2.6-diisopropylphenylimino)-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-pyrimido[6.1-a]isoquinolin-4-onesodium hydroxide二氯甲烷magnesium sulfatemethanol-dichloromethane乙醚 作用下, 以 盐酸 为溶剂, 反应 4.0h, 以afforded the title compound (0.6 g, 17%) as a pale yellow foam的产率得到3-(N-Carbamoyl-2-aminoethyl)-2-(2.6-diisopropylphenylimino)-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-pyrimido[6.1-a]isoquinolin-4-one
    参考文献:
    名称:
    Derivatives of pyrimido[6,1-a]isoquinolin-4-one
    摘要:
    通式(I)的化合物,其中R1和R2各自独立地表示C1-6烷基或C2-7酰基基团;R5表示氢原子或C1-3烷基,C2-3烯基或C2-3炔基基团;R6表示氢原子或C1-6烷基,C2-6烯基,C2-6炔基,氨基,C1-6烷基氨基,双(C1-6)烷基氨基或C2-7酰基氨基基团,R7和R8各自独立地表示氢或卤原子或羟基,三氟甲基,C1-6烷基,C2-6烯基,C2-6炔基,C2-7酰基,C1-6硫基,C1-6烷氧基,C3-6环烷基;R9表示氢或卤原子或羟基,三氟甲基,C1-6烷基,C2-6烯基,C2-6炔基,C2-7酰基,C1-6硫基,C1-6烷氧基或C3-6环烷基基团;X表示OCH2或CR3R4基团,其中R3和R4各自独立地表示氢原子或C1-3烷基基团;R10和R11各自独立地表示氢原子,C1-3烷基,C3-6环烷基或苯基;y表示氧原子或CHNO2,NCN,NH或NNO2基团,n为2至4的整数;或其盐;对治疗哮喘等呼吸系统疾病有用。本发明的化合物比已知化合物trequinsin(9,10-二甲氧基-3-甲基-2-苯基亚胺基-2,3,6,7-四氢-4H-嘧啶[6,1-a]-异喹啉-4-酮)具有更长的作用时间,并且没有trequinsin的非常苦涩的味道。
    公开号:
    US07105663B2
点击查看最新优质反应信息

文献信息

  • Derivatives of pyrimido[6.1-a]isoquinolin-4-one
    申请人:——
    公开号:US20030036542A1
    公开(公告)日:2003-02-20
    The invention provides compounds or salts thereof of the general formula (I): 1 wherein each of R 1 and RX independently represents a C 1-6 alkyl or C 2-7 acyl group; X represents OCH 2 or a group CR 3 R 4 ; wherein each of R 3 or R 4 independently represents a hydrogen atom or a C 1-3 alkyl group; R 5 represents a hydrogen atom or a C 1-3 alkyl, C 2-3 alkenyl or C 2-3 alkynyl group; R 6 represents a hydrogen atom or a C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, amino, C 1-6 alkylamino, di(C 1-6 ) alkylamino or C 2-7 acylamino group; each of R 7 and R 8 independently represents a hydrogen or halogen atom or a hydroxy, trifluoromethyl, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 2-7 acyl, C 1-6 alkylthio, C 1-6 alkoxy, C 3-6 cycloalkyl; and R 9 represents a hydrogen or halogen atom or a hydroxy, trifluoromethyl, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 2-7 acyl, C 1-6 alkylthio, C 1-6 alkoxy or C 3-6 cycloalkyl group. The compounds or salts thereof are useful for treatment of respiratory disorders such as asthma. Compounds of the invention have a longer duration of action than the known compound trequinsin (9,10-dimethoxy-3 methyl-2-mesitylimino-2,3,6,7-tetrahydro- 4 -H-pyrimido[6,1-a]isoquinolin-4-one).
    本发明提供了通式(I)的化合物或其盐: 其中,R1和RX各自独立地表示C1-6烷基或C2-7酰基;X表示OCH2或CR3R4基团;其中,R3或R4各自独立地表示氢原子或C1-3烷基;R5表示氢原子或C1-3烷基、C2-3烯基或C2-3炔基;R6表示氢原子或C1-6烷基、C2-6烯基、C2-6炔基、基、C1-6烷基基、双(C1-6)烷基基或C2-7酰基;R7和R8各自独立地表示氢或卤原子或羟基、三甲基、C1-6烷基、C2-6烯基、C2-6炔基、C2-7酰基、C1-6烷基基、C1-6烷氧基、C3-6环烷基;R9表示氢或卤原子或羟基、三甲基、C1-6烷基、C2-6烯基、C2-6炔基、C2-7酰基、C1-6烷基基、C1-6烷氧基或C3-6环烷基。 该化合物或其盐对于治疗哮喘等呼吸系统疾病有用。本发明的化合物比已知的trequinsin(9,10-二甲氧基-3-甲基-2-间苯基亚胺-2,3,6,7-四氢-4H-嘧啶[6,1-a]异喹啉-4-酮)具有更长的持续时间。
  • Derivatives of pyrimido[6.1-a]isoquinolin-4-one
    申请人:Vernalis Limited
    公开号:US06794391B2
    公开(公告)日:2004-09-21
    The invention provides compounds or salts thereof of the general formula (I): wherein each of R1 and R2 independently represents a C1-6 alkyl or C2-7 acyl group; X represents OCH2 or a group CR3R4; wherein each of R3 or R4 independently represents a hydrogen atom or a C1-3 alkyl group; R5 represents a hydrogen atom or a C1-3 alkyl, C2-3 alkenyl or C2-3 alkynyl group; R6 represents a hydrogen atom or a C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, amino, C1-6 alkylamino, di(C1-6) alkylamino or C2-7 acylamino group; each of R7 and R8 independently represents a hydrogen or halogen atom or a hydroxy, trifluoromethyl, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C2-7 acyl, C1-6 alkylthio, C1-6 alkoxy, C3-6 cycloalkyl; and R9 represents a hydrogen or halogen atom or a hydroxy, trifluoromethyl, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C2-7 acyl, C1-6 alkylthio, C1-6 alkoxy or C3-6 cycloalkyl group. The compounds or salts thereof are useful for treatment of respiratory disorders such as asthma. Compounds of the invention have a longer duration of action than the known compound trequinsin (9,10-dimethoxy-3 methyl-2-mesitylimino-2,3,6,7-tetrahydro-4-H-pyrimido[6,1-a]isoquinolin-4-one).
    本发明提供的化合物或其盐的一般式(I)如下:其中,R1和R2各自表示C1-6烷基或C2-7酰基;X表示OCH2或CR3R4基团;其中,R3或R4各自表示氢原子或C1-3烷基;R5表示氢原子或C1-3烷基、C2-3烯基或C2-3炔基;R6表示氢原子或C1-6烷基、C2-6烯基、C2-6炔基、基、C1-6烷基基、二(C1-6)烷基基或C2-7酰胺基;R7和R8各自表示氢或卤原子或羟基、三甲基、C1-6烷基、C2-6烯基、C2-6炔基、C2-7酰基、C1-6烷基、C1-6烷氧基、C3-6环烷基;R9表示氢或卤原子或羟基、三甲基、C1-6烷基、C2-6烯基、C2-6炔基、C2-7酰基、C1-6烷基、C1-6烷氧基或C3-6环烷基。该化合物或其盐对于治疗哮喘等呼吸系统疾病非常有用。本发明的化合物比已知化合物trequinsin(9,10-二甲氧基-3-甲基-2-间苯基亚基-2,3,6,7-四氢-4H-嘧啶[6,1-a]异喹啉-4-酮)具有更长的作用时间。
  • Derivatives of pyrimido[6, 1-A]isoquinolin-4-one
    申请人:Oxford Alexander William
    公开号:US20080206163A1
    公开(公告)日:2008-08-28
    Compounds of general formula (I) wherein each of R 1 and R 2 independently represents a C 1-6 alkyl or C 2-7 acyl group; R 5 represents a hydrogen atom or a C 1-3 alkyl, C 2-3 alkenyl or C 2-3 alkynyl group; R 6 represents a hydrogen atom or a C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, amino, C 1-6 alkylamino, di(C 1-6 ) alkylamino or C 2-7 acylamino group; each of R 7 and R 8 independently represents a hydrogen or halogen atom or a hydroxy, trifluoromethyl, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 2-7 acyl, C 1-6 alkythio, C 1-6 alkoxy, C 3-6 cycloalkyl; and R 9 represents a hydrogen or halogen atom or a hydroxy, trifluoromethyl, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 2-7 acyl, C 1-6 alkythio, C 1-6 alkoxy or C 3-6 cycloalkyl group; X represents OCH 2 or a group CR 3 R 4 , wherein each of R 3 and R 4 independently represents a hydrogen atom or a C 1-3 alkyl group; each of R 10 and R 11 independently represents a hydrogen atom, a C 1-3 alkyl, C 3-6 cycloalkyl or phenyl group; y represents an oxygen atom or a group CHNO 2 , NCN, NH or NNO 2 , n is an integer from 2 to 4; or a salt thereof; are useful for treatment of respiratory disorders such as asthma. Compounds of the invention have a longer duration of action than the known compound trequinsin (9,10-dimethoxy-3-methyl-2-mesitylimino-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one) and do not have trequinsin's very bitter taste.
    通式(I)的化合物,其中R1和R2各自独立地表示C1-6烷基或C2-7酰基基团;R5表示氢原子或C1-3烷基,C2-3烯基或C2-3炔基基团;R6表示氢原子或C1-6烷基,C2-6烯基,C2-6炔基,基,C1-6烷基基,二(C1-6)烷基基或C2-7酰胺基团;R7和R8各自独立地表示氢或卤原子,或羟基,三甲基,C1-6烷基,C2-6烯基,C2-6炔基,C2-7酰基,C1-6烷基,C1-6烷氧基,C3-6环烷基;R9表示氢或卤原子,或羟基,三甲基,C1-6烷基,C2-6烯基,C2-6炔基,C2-7酰基,C1-6烷基,C1-6烷氧基或C3-6环烷基;X表示OCH2或CR3R4基团,其中R3和R4各自独立地表示氢原子或C1-3烷基;R10和R11各自独立地表示氢原子,C1-3烷基,C3-6环烷基或苯基;y表示氧原子或CHNO2,NCN,NH或NNO2基团,n为2到4的整数;或其盐;可用于治疗哮喘等呼吸系统疾病。本发明的化合物比已知化合物特雷昆辛(9,10-二甲氧基-3-甲基-2-间苯基亚胺-2,3,6,7-四氢-4H-嘧啶[6,1-a]异喹啉-4-酮)具有更长的作用时间,并且不具有特雷昆辛的非常苦涩的味道。
  • DERIVATIVES OF PYRIMIDO [6,1-A] ISOQUINOLIN-4-ONE
    申请人:Oxford Alexander William
    公开号:US20120302533A1
    公开(公告)日:2012-11-29
    The present invention relates to derivatives of pyrimido[6,1-a]isoquinolin-4-one and their application as inhibitors of phosphodiesterase (PDE) isoenzymes. More particularly the invention relates to derivatives of pyrimido[6,1-a]isoquinolin-4-one and their use in medicine for example as bronchodilators with anti-inflammatory properties.
    本发明涉及嘌呤并[6,1-a]异喹啉-4-酮的衍生物及其作为磷酸二酯酶(PDE)同工酶抑制剂的应用。更具体地,本发明涉及嘌呤并[6,1-a]异喹啉-4-酮的衍生物及其在医学上的应用,例如作为具有抗炎作用的支气管扩张剂。
  • Derivatives of pyrimido[6,1-A]isoquinolin-4-one
    申请人:Verona Pharma plc
    公开号:US08242127B2
    公开(公告)日:2012-08-14
    The present invention relates to derivatives of pyrimido[6,1-a]isoquinolin-4-one and their application as inhibitors of phosphodiesterase (PDE) isoenzymes. More particularly the invention relates to derivatives of pyrimido[6,1-a]isoquinolin-4-one and their use in medicine for example as bronchodilators with anti-inflammatory properties.
    本发明涉及嘧啶并[6,1-a]异喹啉-4-酮的衍生物及其作为磷酸二酯酶(PDE)同工酶抑制剂的应用。更具体地,本发明涉及嘧啶并[6,1-a]异喹啉-4-酮的衍生物及其在医药领域中的应用,例如作为具有抗炎性能的支气管扩张剂。
查看更多

同类化合物

阿昔替酯 螺喹唑啉 苯并[g][1,2,3]三唑并[4',5':5,6]吡啶并[2,1-b]喹唑啉-13(2H)-酮 脱氢利培酮 盐酸曲林菌素 甲硫利马唑 甲基8-乙基-2-甲氧基-5-氧代-5,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸酯 甲基8-乙基-2-(甲硫基)-5-氧代-5,6,7,8-四氢吡啶并[2,3-d]嘧啶-6-羧酸酯 甲基2-乙氧基-8-乙基-5-氧代-吡啶并[6,5-d]嘧啶-6-羧酸酯 溴他替尼 泮托拉唑杂质DF 氨甲酸,[(2R,3E)-2-羟基-3-戊烯基]-,1,1-二甲基乙基酯(9CI) 柱孢藻毒素 曲美替尼 曲美替尼 曲喹辛 异噻唑并[5,4-d]嘧啶,3-亚硝基-(9CI) 帕潘立酮棕榈酸酯 帕潘立酮杂质7 帕潘立酮杂质16 帕潘立酮杂质 帕潘立酮杂质 帕潘立酮去氟杂质 帕潘立酮Z-异构体 帕潘立酮 帕泊昔布杂质117 帕布昔利布杂质46 帕博西尼杂质S 帕利哌酮杂质05 帕利哌酮杂质03 帕利哌酮杂质02 帕利哌酮十四酸酯 帕利哌酮N-氧化物 布喹特林 巴马斯汀 奥卡哌酮 多夸司特 嘧啶并[4,5-d]嘧啶-2,4,5(1H,3H,6H)-三酮,7-乙氧基-1,3-二甲基-6-(苯基甲基)- 吡曲克辛 吡嘧司特钾 吡嘧司特 吡啶并[4,3-d]嘧啶-4(1H)-酮,4,5,6,7-四氢-6-甲基-2-苯基- 吡啶并[4,3-D]嘧啶-2,4(1H,3H)-二酮 吡啶并[3,4-D]嘧啶-2,4(1H,3H)-二酮 吡啶并[3,2-d]嘧啶-4(3H)-酮,3-甲基-2-(甲基氨基)- 吡啶并[3,2-d]嘧啶-4(3H)-酮 吡啶并[3,2-d]嘧啶-4(1H)-酮,2,3-二氢-3-(2-羟基苯基)-2-硫代- 吡啶并[3,2-d]嘧啶-2,4(1H,3H)-二酮 吡啶并[2,3-d]嘧啶-7(8h)-酮,2,6-二溴-8-环戊基-5-甲基- 吡啶并[2,3-d]嘧啶-7(8H)-酮